Skip to content

NPS PHARMACEUTICALS INC

CIK 0000890465

← back to feed
Revenue (TTM)
$196.57M
+16.6% YoY FY Feb 2015
Net Income (TTM)
−$7.82M
+35.5% YoY FY Feb 2015
EPS Diluted (TTM)
−$0.07
0.0% YoY FY Feb 2015
Gross Margin
95.5%
FY Feb 2015
Operating Margin
3.0%
FY Feb 2015
Net Margin
-4.0%
FY Feb 2015
Free Cash Flow (TTM)
—
FY Feb 2015
Cash
$65.57M
FY Feb 2015
Total Debt
$100.01M
FY Feb 2015
Shares Outstanding
108.58M sh
FY Feb 2015

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings